SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-093565
Filing Date
2024-11-01
Accepted
2024-11-01 17:00:08
Documents
13
Period of Report
2024-10-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea021963001-8k_avalonglobo.htm   iXBRL 8-K 23922
  Complete submission text file 0001213900-24-093565.txt   197838

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE albt-20241029.xsd EX-101.SCH 3048
3 XBRL LABEL FILE albt-20241029_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE albt-20241029_pre.xml EX-101.PRE 22381
15 EXTRACTED XBRL INSTANCE DOCUMENT ea021963001-8k_avalonglobo_htm.xml XML 3686
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 241419850
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)